Intriguingly, this study revealed that NSUN5 could act as an immune therapy target to transform glioma into a “warm tumour” and lead to impressive therapeutic outcomes when NSUN5 is restored in IDH1-R132H mutant glioma cells. The gene discussed is IDH1; the disease is central nervous system cancer.